Skip to Main Content

Author Details

Camilo E Fadul
University of Virginia Health System
1987
93
33
PMIDPaper TitleJournal TitlePublished Year
36288512Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic <i>NF2</i> Mutations.J Clin Oncol2023
37370865Relevance of the Updated Recursive Partitioning Analysis (U-RPA) Classification in the Contemporary Care of Patients with Brain Metastases.Cancers (Basel)2023
37227650Contemporary care for brain metastasis patients: multidisciplinary approaches and the role of prospective national registries.J Neurooncol2023
36884200Systematic review of the management of brain metastases from hormone receptor positive breast cancer.J Neurooncol2023
35953567MRI features predict tumor grade in isocitrate dehydrogenase (IDH)-mutant astrocytoma and oligodendroglioma.Neuroradiology2023
36600773Melanoma brain metastasis mimicking cortical laminar necrosis.Surg Neurol Int2022
35857249The landscape of brain tumor mimics in neuro-oncology practice.J Neurooncol2022
32780641Genesis of Quality Measurements to Improve the Care Delivered to Patients With Brain Metastases.JCO Oncol Pract2021
33926689Imaging Mimics of Brain Tumors.Radiol Clin North Am2021
33661425Fluid attenuation in non-contrast-enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in Glioblastoma.J Neurooncol2021
34777831A window into the care needs of patients with brain metastases.Neurooncol Pract2021
34654708Safety and Immune Effects of Blocking CD40 Ligand in Multiple Sclerosis.Neurol Neuroimmunol Neuroinflamm2021
34652553Systemic coagulation is activated in patients with meningioma and glioblastoma.J Neurooncol2021
32401669Diffuse large B-cell lymphoma relapse presenting as extensive neurolymphomatosis.Neuroradiol J2020
31714193MRI and CT Identify Isocitrate Dehydrogenase <i>(IDH)</i>-Mutant Lower-Grade Gliomas Misclassified to 1p/19q Codeletion Status with Fluorescence in Situ Hybridization.Radiology2020
31856602Adaptive dose-finding based on safety and feasibility in early-phase clinical trials of adoptive cell immunotherapy.Clin Trials2020
32902767Intracranial disease control for EGFR-mutant and ALK-rearranged lung cancer with large volume or symptomatic brain metastases.J Neurooncol2020
32327434Prognostic Value of Preoperative MRI Metrics for Diffuse Lower-Grade Glioma Molecular Subtypes.AJNR Am J Neuroradiol2020
30705071Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in <i>IDH</i>-Mutant Lower Grade Gliomas.AJNR Am J Neuroradiol2019
31757377Clinical and Radiographic Response of Leptomeningeal and Brain Metastases to Encorafenib and Binimetinib in a Patient With BRAF V600E-Mutated Lung Adenocarcinoma.J Thorac Oncol2019
31832212Checkpoint inhibitor failure in hypermutated and mismatch repair-mutated recurrent high-grade gliomas.Neurooncol Pract2019
31349225Stereotactic radiosurgery with and without checkpoint inhibition for patients with metastatic non-small cell lung cancer to the brain: a matched cohort study.J Neurosurg2019
31549281Oligodendroglioma confers higher risk of radiation necrosis.J Neurooncol2019
31399936Tumor pharmacokinetics and pharmacodynamics of the CDK4/6 inhibitor ribociclib in patients with recurrent glioblastoma.J Neurooncol2019
31248860Extent of Surgical Resection in Lower-Grade Gliomas: Differential Impact Based on Molecular Subtype.AJNR Am J Neuroradiol2019
28961956Tremor Secondary to a Thalamic Glioma: A Case Report.Oper Neurosurg (Hagerstown)2018
30073641Palliative care education in U.S. adult neuro-oncology fellowship programs.J Neurooncol2018
30072065Neurologic and Medical Management of Brain Tumors.Neurol Clin2018
29959694Features of diffuse gliomas that are misdiagnosed on initial neuroimaging: a case control study.J Neurooncol2018
27942839Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma.Cancer Immunol Immunother2017
28166733A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.BMC Genomics2017
28427986Prognostic Implications of Extent of Resection in Glioblastoma: Analysis from a Large Database.World Neurosurg2017
28515935Methotrexate encephalopathy: Two cases in adult cancer patients, who recovered with pathophysiologically based therapy.SAGE Open Med Case Rep2017
26603828Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.Eur J Cancer Care (Engl)2017
26974965The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells.Melanoma Res2016
31386082A clinical care pathway to improve the acute care of patients with glioma.Neurooncol Pract2016
278861745-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patients.Nat Commun2016
26902850A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy.Neuro Oncol2016
25618892Regulatory T cells are not a strong predictor of survival for patients with glioblastoma.Neuro Oncol2015
26205736Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center.Oncologist2015
24740196A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the Brain Tumor Investigational Consortium (BTIC).J Neurooncol2014
25294392Improving the quality of care for patients diagnosed with glioma during the perioperative period.J Oncol Pract2014
25097758Letter to the editor.J Immunother Cancer2014
22795806Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size.Int J Radiat Oncol Biol Phys2013
25054578Vaccine-based immunotherapy for glioblastoma.CNS Oncol2013
24312360Serine/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastoma.PLoS One2013
24166348Anti-N-methyl-D-aspartate receptor encephalitis: a patient with refractory illness after 25 months of intensive immunotherapy.JAMA Neurol2013
23553268Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.Neuro Oncol2013
23549581Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.JAMA2013
23232808A phase II trial of oral gimatecan for recurrent glioblastoma.J Neurooncol2013
  • 1 - 50 of 93

Recommended Authors

Nancy Wang
Massachusetts General Hospital Cancer Center, Harvard Medical School
Career Start Year 2013
Number of shared co-authors 3
Yoshua Esquenazi
McGovern Medical School at UT Health Houston
Career Start Year 2007
Number of shared co-authors 0
Sherise D Ferguson
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 1
Adam M Sonabend
Northwestern University
Career Start Year 2005
Number of shared co-authors 2
Nicholas Butowski
University of California san francisco
Career Start Year 2005
Number of shared co-authors 7
Gelareh Zadeh
University of Toronto
Career Start Year 2003
Number of shared co-authors 9
Matthias Preusser
Medical University of Vienna
Career Start Year 2003
Number of shared co-authors 6
Martin Glas
University Hospital Essen
Career Start Year 2002
Number of shared co-authors 0
Andrew P Morokoff
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year 2001
Number of shared co-authors 0
Mariza Daras
University of California san francisco
Career Start Year 2001
Number of shared co-authors 3
Ghazaleh Tabatabai
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 1998
Number of shared co-authors 2
Martin Hunn
0The Alfred Hospital
Career Start Year 1997
Number of shared co-authors 0
Warren P Mason
Princess Margaret Cancer Centre
Career Start Year 1996
Number of shared co-authors 5
Vinay K Puduvalli
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 4
Clark C Chen
University of Minnesota
Career Start Year 1994
Number of shared co-authors 2
David M Peereboom
Brain Tumor & Neuro-Oncology Cleveland Clinic Main Campus
Career Start Year 1993
Number of shared co-authors 6
Timothy F Cloughesy
David Geffen School of Medicine, University of California Los Angeles
Career Start Year 1992
Number of shared co-authors 7
Howard Colman
Huntsman Cancer Institute, University of Utah
Career Start Year 1990
Number of shared co-authors 7
Roger Stupp
Northwestern University
Career Start Year 1990
Number of shared co-authors 5
Howard A Fine
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 2
G??nther Stockhammer
Medical University of Innsbruck
Career Start Year 1990
Number of shared co-authors 0
Tom Mikkelsen
Ontario Brain Institute
Career Start Year 1990
Number of shared co-authors 7
Morris D Groves
The University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 4
Christine Marosi
Medical University of Vienna
Career Start Year 1987
Number of shared co-authors 0
Michael Weller
University Hospital and University of Zurich
Career Start Year 1987
Number of shared co-authors 6
Michael D Prados
University of California san francisco
Career Start Year 1987
Number of shared co-authors 7
Ryo Nishikawa
Saitama Medical University International Medical Center
Career Start Year 1986
Number of shared co-authors 3
Michael A Vogelbaum
Moffit Cancer Center
Career Start Year 1986
Number of shared co-authors 6
Robert Aiken
Rutgers Cancer Institute of New Jersey, Rutgers University
Career Start Year 1984
Number of shared co-authors 3
Wai-Kwan Alfred Yung
University of Texas M.D. Anderson Cancer Center
Career Start Year 1974
Number of shared co-authors 3

Collaborators

David Schiff
University of Virginia School of Medicine
Co-authored papers 13
Thomas H Hampton
Geisel School of Medicine, Dartmouth College
Co-authored papers 8
Rajan Jain
Co-authored papers 7
Jiang Gui
Geisel School of Medicine at Dartmouth
Co-authored papers 5
Patrick Y Wen
Co-authored papers 4
Gregory J Tsongalis
Dartmouth Health and the Dartmouth Cancer Center, USA Geisel School of Medicine
Co-authored papers 4
Andrew J Saykin
Indiana University School of Medicine
Co-authored papers 3
Arief A Suriawinata
Dartmouth Hitchcock Medical Center
Co-authored papers 3
Tor D Tosteson
Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center
Co-authored papers 3
John Mongan
University of California San Francisco
Co-authored papers 2
Brent T Harris
Co-authored papers 2
Craig R Tomlinson
Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth
Co-authored papers 2
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Brock C Christensen
Geisel School of Medicine, Dartmouth College
Co-authored papers 2
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 1
Yolanda Sanchez
Collegeville
Co-authored papers 1
Rosina T Lis
National Cancer Institute
Co-authored papers 1
Johanna Loomba
Integrated Translational Health Research Institute of Virginia (iTHRIV)
Co-authored papers 1
Susan Geyer
Division of Clinical Trials and Biostatistics, Mayo Clinic
Co-authored papers 1
Priscilla K Brastianos
Co-authored papers 1
Maria Martinez-Lage
Massachusetts General Hospital
Co-authored papers 1
Nicole Shonka
Co-authored papers 1
Daniel J Brat
Co-authored papers 1
Casey S Greene
Co-authored papers 1
Anthony J Iafrate
Massachusetts General Hospital
Co-authored papers 1
Jaclyn A Biegel
Co-authored papers 1
Priya Kumthekar
Northwestern University, Feinberg School of Medicine
Co-authored papers 1
Michael D Cusimano
St. Michael's Hospital, University of Toronto
Co-authored papers 1
Casey S Greene
Dartmouth College Geisel School of Medicine, Princeton University, University of Colorado Anschutz Medical Campus, University of Pennsylvania Perelman School of Medicine
Co-authored papers 1
Charles L Loprinzi
Mayo Clinic
Co-authored papers 1
Release 1.2